Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice.

Source:http://linkedlifedata.com/resource/pubmed/id/1568223

Cancer Res. 1992 May 1 52 9 2538-44

Download in:

View as

General Info

PMID
1568223